Not marginal but central: type I interferons unleash marginal zone B cells in Sjögren's disease. [PDF]
Cell Mol ImmunolWerynski A +4 more
europepmc +1 more source
A novel murine model of Sjögren's disease using lacrimal autoantigen. [PDF]
Front ImmunolLi S +6 more
europepmc +1 more source
Hypertransaminasemia in a Patient with Acute Abdominal Pain: An Unusual Case Report. [PDF]
Eur J Case Rep Intern MedFacciuto AI +6 more
europepmc +1 more source
A novel role for the E2F transcription factor and the ER stress sensor IRE1 in cytoplasmic DNA accumulation. [PDF]
GeneticsDas A, Li Y, Fan Y, Moon NS.
europepmc +1 more source
Adjunctive Molecular Hydrogen Therapy Modulates T Cell Markers and Reduces Anti-Ro Antibody in Refractory Oral Ulcers of Behçet's Disease and Sjögren's Syndrome: A Case Report. [PDF]
In VivoLin CC +6 more
europepmc +1 more source
Pathological Mechanisms in Sjögren's Disease Likely Involve the ADP-Ribosyl Cyclase Family Members: CD38 and CD157. [PDF]
Int J Mol SciRosecka M +6 more
europepmc +1 more source
Non-Conventional and Emerging Autoantibodies in Sjögren's Disease. [PDF]
J Inflamm ResLee AYS.
europepmc +1 more source
Review of research on pulmonary cysts in sjögren's syndrome. [PDF]
J Cardiothorac SurgPan CH, Zhang XF, Chen C, An XB.
europepmc +1 more source
Update on the Aetiopathogenesis of Sjögren Disease: From Interferon Signaling to Epithelial Dysfunction. [PDF]
J Clin MedMeudec L, Nocturne G, Mariette X.
europepmc +1 more source
Heart failure with preserved ejection fraction beyond the heart: exploring the heart-liver-pancreas axis. [PDF]
ESC Heart FailTun HN +4 more
europepmc +1 more source